Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study
M. Lahouati, Charles Cazanave, Aur lie Labadie, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10

Showing 10 citing articles:

Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England
Vishal Patel, Bethany Levick, Stephen Boult, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study
Salvatore Rotundo, Lavinia Berardelli, Sara Palma Gullì, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity
Raymund R. Razonable
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
How I treat: Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients
Dionysios Neofytos, Nina Khanna
Transplant Infectious Disease (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 3
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients
Chiara Sepulcri, Claudia Bartalucci, Małgorzata Mikulska
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 506-517
Closed Access | Times Cited: 2
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis
Behnam Amani, Bahman Amani
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 7, pp. 547-555
Closed Access | Times Cited: 1
Efficacy of late-onset antiviral treatment in immune-compromised hosts with persistent SARS-CoV-2 infection
Carolin M. Lieber, Hae-Ji Kang, Elizabeth B. Sobolik, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection
Carolin M. Lieber, Hae-Ji Kang, Elizabeth B. Sobolik, et al.
Journal of Virology (2024) Vol. 98, Iss. 9
Closed Access | Times Cited: 1
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era
Serena Vita, Emanuela Giombini, Patrizia De Marco, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2024043-e2024043
Open Access
Real-world evidence of sotrovimab effectiveness for preventing severe outcomes in patients with COVID-19: A quality improvement propensity matched retrospective cohort study of a pan-provincial program in Alberta, Canada
Gregory Farmer, Khokan C. Sikdar, TKT Lo, et al.
International Journal of Infectious Diseases (2024) Vol. 146, pp. 107136-107136
Closed Access
Page 1

Scroll to top